This site is intended for healthcare professionals.
VYNDAMAX access starts here
Partnering with you to support your patients’ ability to access their prescription
Broad access, real impact
VYNDAMAX is widely accessible—more than 90% of patients with Medicare or commercial insurance can start on therapy* after meeting standard prior authorization or formulary exception criteria.† That means nearly every eligible prescribed patient has a path to treatment.